客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 17/188 每页显示数量
CryoEM of endogenous mammalian V-ATPase interacting with the TLDc protein mEAK-7
Authors: Yong Zi Tan, Yazan M Abbas, Jing Ze Wu, Di Wu, Kristine A Keon, Geoffrey G Hesketh, Stephanie A Bueler, Anne-Claude Gingras, Carol V Robinson, Sergio Grinstein, John L Rubinstein
Journal: Life Sci Alliance
PubMed ID: 35794005
Doi: 10.26508/lsa.202201527
Products & Services: Custom Vector Construction   
Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors
Authors: Jorge Franco, Francesco Piacente, Melanie Walter, Simone Fratta, Moustafa Ghanem, Andrea Benzi, Irene Caffa, Alexander V Kurkin, Andrea Altieri, Patrick Herr, Macarena Martínez-Bailén, Inmaculada Robina, Santina Bruzzone, Alessio Nencioni, Alberto Del Rio
Journal: Pharmaceuticals (Basel)
PubMed ID: 35890155
Doi: 10.3390/ph15070855
Products & Services: Custom Vector Construction   
Oral Administration with Recombinant Attenuated Regulated Delayed Lysis Vaccines Protecting against Kidney Abscess Formation
Authors: Yanchen Liang, Haochi Zhang, Na Pan, Yang Liu, Shouxin Sheng, Haotian Li, Xuemei Bao, Xiao Wang
Journal: Vaccines (Basel)
PubMed ID: 35891237
Doi: 10.3390/vaccines10071073
Products & Services: Custom Vector Construction   
Overexpression of the scopoletin biosynthetic pathway enhances lignocellulosic biomass processing
Authors: Lennart Hoengenaert, Marlies Wouters, Hoon Kim, Barbara De Meester, Kris Morreel, Steven Vandersyppe, Jacob Pollier, Sandrien Desmet, Geert Goeminne, John Ralph, Wout Boerjan, Ruben Vanholme
Journal: Sci Adv
PubMed ID: 35857515
Doi: 10.1126/sciadv.abo5738
Products & Services: Custom Vector Construction   
An effective strategy for the humanization of antibody fragments under an accelerated timeline
Authors: Isabella Gizzi Jiacomini, Martina Beltramino, Fanny Boursin, João Carlos Minozzo, Juliana Ferreira de Moura, Philippe Billiald, Larissa Magalhães Alvarenga, Nicolas Aubrey
Journal: Int J Biol Macromol
PubMed ID: 35803408
Doi: 10.1016/j.ijbiomac.2022.06.195
Products & Services: Custom Vector Construction   
Discovery of archaeal fusexins homologous to eukaryotic HAP2/GCS1 gamete fusion proteins
Authors: David Moi, Shunsuke Nishio, Xiaohui Li, Clari Valansi, Mauricio Langleib, Nicolas G Brukman, Kateryna Flyak, Christophe Dessimoz, Daniele de Sanctis, Kathryn Tunyasuvunakool, John Jumper, Martin Graña, Héctor Romero, Pablo S Aguilar, Luca Jovine, Benjamin Podbilewicz
Journal: Nat Commun
PubMed ID: 35794124
Doi: 10.1038/s41467-022-31564-1
Products & Services: Custom Vector Construction   
Anti-Ischemic Effects of PIK3IP1 Are Mediated through Its Interactions with the ET-PI3Kγ-AKT Axis
Authors: Jei Hyoung Park, Kyoung Jin Nho, Ji Young Lee, Yung Joon Yoo, Woo Jin Park, Chunghee Cho, Do Han Kim
Journal: Cells
PubMed ID: 35883611
Doi: 10.3390/cells11142162
Products & Services: Custom Vector Construction   
Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration, invasion, and self-renewal
Authors: Huiyun Liu, Daniel Heller-Trulli, Claire L Moore
Journal: iScience
PubMed ID: 35992060
Doi: 10.1016/j.isci.2022.104804
Products & Services: Custom Vector Construction   
A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice
Authors: Lihong He, Wenqiang Sun, Limin Yang, Wenjun Liu, Jing Li
Journal: Virol Sin
PubMed ID: 35835315
Doi: 10.1016/j.virs.2022.07.003
Products & Services: Custom Vector Construction   
FOXM1 regulates glycolysis and energy production in multiple myeloma
Authors: Yan Cheng, Fumou Sun, Krista Thornton, Xuefang Jing, Jing Dong, Grant Yun, Michael Pisano, Fenghuang Zhan, Sung Hoon Kim, John A Katzenellenbogen, Benita S Katzenellenbogen, Parameswaran Hari, Siegfried Janz
Journal: Oncogene
PubMed ID: 35794249
Doi: 10.1038/s41388-022-02398-4
Products & Services: Custom Vector Construction   

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*